A problem‐solving approach to stress reduction among younger women with breast carcinoma

Allen, Susan; Shah, Ann; Nezu, Arthur M.; Nezu, Christine Maguth; Ciambrone, Desirée; Hogan, Joseph W.; Mor, Vincent

doi:10.1002/cncr.10586

Cited by 135 publications

(97 citation statements)

References 70 publications

(71 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…32 Studies have described interventions combining face-to-face with telephone contact with positive outcomes. [33][34][35] For instance, in the UK an RCT with over 300 patients found that a very brief cognitive behavioural therapy (CBT) intervention promoted earlier adjustment to illness among patients at high risk of developing affective disorders. 35 …”

Section: Telephone Counsellingmentioning

confidence: 99%

Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?

Shepherd¹,

Goldstein²,

Olver³

et al. 2008

Aust. Health Review

View full text Add to dashboard Cite

Rural cancer patients are often disadvantaged in access to psychological services. We reviewed remote counselling research for psychological support using telephone, videoconferencing, and the Internet as a potential solution. Telephone counselling is the most extensively researched, while there are encouraging findings in emerging research about videoconferencing and Internetbased psychological care. Where no face-to-face psychological service exists, these technologies are promising, yet unproven. Less variable methods are needed to better assess the technology and therapeutic approach for stronger evidence.

show abstract

Section: Telephone Counsellingmentioning

confidence: 99%

Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?

Shepherd¹,

Goldstein²,

Olver³

et al. 2008

Aust. Health Review

View full text Add to dashboard Cite

show abstract

“…However, the benefits of the intervention over standard care did not reach statistical significance for regimens within the moderate/high or low emetogenic groups. The evidence was inconclusive regarding which patients have the most unmet needs, 10,11 or whether screening for unmet needs may improve patient-reported outcomes. 13,30 The findings of the current study support that telephone-based nursing care is appropriate and acceptable, [10][11][12]15 yet the optimal dose intensity or timing for all patients remain elusive.…”

Section: Discussionmentioning

confidence: 99%

“…The evidence was inconclusive regarding which patients have the most unmet needs, 10,11 or whether screening for unmet needs may improve patient-reported outcomes. 13,30 The findings of the current study support that telephone-based nursing care is appropriate and acceptable, [10][11][12]15 yet the optimal dose intensity or timing for all patients remain elusive. 31 Although the current intervention did not affect patient-reported outcomes, the entire sample demonstrated patterns of change, which can inform future work.…”

Section: Discussionmentioning

confidence: 99%

“…Results were mixed for patient-reported outcomes such as fatigue, pain, psychological distress, and QOL. [10][11][12][13][14][15][16] Outpatient oncology involves a complex system of medical, nursing, and other providers. 15 Prior intervention effects possibly might be enhanced by having patients' own providers deliver visits for managing symptoms, prescribing medications, and titrating doses.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Nursing intervention to enhance outpatient chemotherapy symptom management: Patient‐reported outcomes of a randomized controlled trial

Traeger

McDonnell

McCarty

et al. 2015

Cancer

View full text Add to dashboard Cite

BACKGROUND:The authors conducted a randomized controlled trial to evaluate a nurse practitioner (NP)-delivered symptom management intervention for patients initiating chemotherapy for nonmetastatic cancer. The aim was to reduce patient-reported symptom burden by facilitating patient-NP collaboration and the early management of symptoms. METHODS: At the time of the first chemotherapy visit, adult participants with nonmetastatic breast, colorectal, or lung cancer (120 participants) completed self-report measures and were then randomly assigned to standard care plus the intervention or standard care alone. Intervention participants received proactive telephone calls from their oncology team NP during the week after each of the first 2 chemotherapy administration visits. Measures were repeated at the second and third chemotherapy visits. Group differences were analyzed with regard to patient-reported symptoms (Memorial Symptom Assessment Scale-Short Form items), satisfaction with care (Family Caregiver Satisfaction-patient scale), and the likelihood of depression or anxiety symptoms (Patient Health Questionnaire-4). RESULTS: At the time of the first visit, 50.8% of participants reported 1 physical symptom, most commonly lack of energy (35.8%) and drowsiness (30.8%). The number of symptoms (gamma coefficient [g] 5 0.16; P<.001), symptom distress (g 5 0.45; P<.001), and satisfaction with care (g 5 0.24; P 5 .004) increased whereas the likelihood of anxiety symptoms decreased (g 5 -0.19; P 5 .02) and the likelihood of depression symptoms did not change (g 5 0.01; P 5 .91). Outcomes did not differ by randomized group. Randomized group interacted with emetogenic potential in predicting symptom distress (c 5 0.43; P 5 .03) and satisfaction with care (c 5 -0.45; P 5 .045). CONCLUSIONS: The intervention did not appear to reduce symptom burden compared with standard care. Early symptoms highlight the importance of continuing to examine strategies to improve symptom management during chemotherapy for nonmetastatic disease. Cancer 2015;121:3905-13.

show abstract

“…45 Eligible patients were recruited from a network of sites in Rhode Island, southeastern Massachusetts, Philadelphia, and Newark, New Jersey, between April 1996 and November 1999. Study eligibility criteria included women aged 50 or younger who had no prior history of breast cancer, who had a tissueconfirmed diagnosis of stage I to IIIA tumors, and who were initiating their first course of chemotherapy treatment.…”

Section: Samplementioning

confidence: 99%

Use of Complementary Therapies During Chemotherapy: Influence of Patients’ Satisfaction With Treatment Decision Making and the Treating Oncologist

et al. 2006

View full text Add to dashboard Cite

The relationship between the use of complementary therapy (CT) and satisfaction with medical treatment decision making and with the treating oncologist was evaluated in a sample of 166 women who were undergoing an initial course of chemotherapy for early-stage breast cancer. At the beginning of chemotherapy, 39% indicated already trying CT and an additional 13% reported planning to try CT. These women mentioned a variety of vitamin, nutritional, herbal, physical, mental, and spiritual approaches. Four months later, when most patients had completed chemotherapy, more than half (53%) reported using CT, with another 8% planning to try it. Regression analysis controlling for psychosocial and medical variables revealed that women who were younger and less satisfied with their treatment decisionmaking experience were significantly more likely to use CT. When predicting use of CT at the conclusion of treatment, baseline utilization was the greatest predictor, but dissatisfaction with the oncologist was also a significant predictor. These findings suggest that patients who are dissatisfied with their medical care may be more likely to use CT during treatment. Further research is needed to elucidate the relationship between satisfaction with medical decision making and the patient-physician relationship to CT use among cancer patients. The findings also highlight the importance of good patient-physician communication about CT use throughout the cancer treatment experience. Keywords: breast cancer; complementary therapy; patientphysician communication; satisfaction with medical decision makingThe use of complementary and alternative therapies by cancer patients has steadily increased over the past decade, 1-6 particularly among women with breast cancer.7-10 While findings regarding the characteristics of women who use complementary therapy (CT) are relatively consistent across studies, not much is known about the stimuli that influence the decision to use CT during conventional cancer treatment. For example, while there is some evidence that patientphysician communication about breast cancer treatment decisions may be frustrating for women, 11,12 it is not yet clear how patient satisfaction with this exchange may be related to CT use. This article presents data on CT utilization among breast cancer patients undergoing chemotherapy with an emphasis on the relationship between CT use and patients' satisfaction with medical treatment decision making as well as with their medical oncologist. Prevalence and Correlates of CT Use Among Women With Breast CancerEstimates suggest that most adult cancer patients use some form of CT.13-16 CT use appears particularly prevalent among women with breast cancer relative to other illness populations. 3,17,18 In one study, breast cancer patients were twice as likely to report using CT than were prostate cancer or gastrointestinal cancer patients. 19 The lack of a concise definition of CT has hindered studies from providing reliable use estimates and has made comparisons across studies diffi...

show abstract

A problem‐solving approach to stress reduction among younger women with breast carcinoma

Cited by 135 publications

References 70 publications

Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?

Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?

Nursing intervention to enhance outpatient chemotherapy symptom management: Patient‐reported outcomes of a randomized controlled trial

Use of Complementary Therapies During Chemotherapy: Influence of Patients’ Satisfaction With Treatment Decision Making and the Treating Oncologist

Contact Info

Product

Resources

About